Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$0.97 USD
-0.04 (-4.15%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $0.96 -0.01 (-0.83%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -51.28% |
ABR | 1.67 |
Earnings ESP
|
-8.70% |
---|---|
Current Year | -3.13 |
Next Year | -1.51 |
EPS (TTM) | -7.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.40 | -3.13 | -1.51 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.50 | -0.41 | -3.26 | -1.51 |
High Estimate | -0.42 | -0.39 | -3.00 | -1.51 |
Low Estimate | -0.50 | -0.41 | -3.26 | -1.51 |
Year ago EPS | -1.14 | NA | -4.91 | -3.13 |
Year over Year Growth Est. | 59.65% | NA | 36.25% | 51.76% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.40 | -3.13 | -1.51 |
7 Days Ago | -0.46 | -0.40 | -3.13 | -1.51 |
30 Days Ago | -0.41 | -0.40 | -2.33 | -1.51 |
60 Days Ago | -0.41 | -0.40 | -2.33 | -1.51 |
90 Days Ago | -0.37 | -0.37 | -1.51 | -1.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.40 | -3.26 | -1.51 |
Zacks Consensus Estimate | -0.46 | -0.40 | -3.13 | -1.51 |
Earnings ESP | -8.70% | 0.00% | -4.15% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.68 | NA | -1.14 | NA |
Estimate | -0.39 | -0.51 | NA | -1.14 | NA |
Difference | -0.20 | -0.17 | NA | 0.00 | -0.12 |
Surprise | -51.28% | -33.33% | NA | 0.00% | -28.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more